Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 52.8 NOK -2.76% Market Closed
Market Cap: 1.4B NOK
Have any thoughts about
Photocure ASA?
Write Note

Intrinsic Value

The intrinsic value of one PHO stock under the Base Case scenario is 69.19 NOK. Compared to the current market price of 52.8 NOK, Photocure ASA is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHO Intrinsic Value
69.19 NOK
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Photocure ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PHO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PHO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Photocure ASA

Provide an overview of the primary business activities
of Photocure ASA.

What unique competitive advantages
does Photocure ASA hold over its rivals?

What risks and challenges
does Photocure ASA face in the near future?

Summarize the latest earnings call
of Photocure ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Photocure ASA.

Provide P/S
for Photocure ASA.

Provide P/E
for Photocure ASA.

Provide P/OCF
for Photocure ASA.

Provide P/FCFE
for Photocure ASA.

Provide P/B
for Photocure ASA.

Provide EV/S
for Photocure ASA.

Provide EV/GP
for Photocure ASA.

Provide EV/EBITDA
for Photocure ASA.

Provide EV/EBIT
for Photocure ASA.

Provide EV/OCF
for Photocure ASA.

Provide EV/FCFF
for Photocure ASA.

Provide EV/IC
for Photocure ASA.

Show me price targets
for Photocure ASA made by professional analysts.

What are the Revenue projections
for Photocure ASA?

How accurate were the past Revenue estimates
for Photocure ASA?

What are the Net Income projections
for Photocure ASA?

How accurate were the past Net Income estimates
for Photocure ASA?

What are the EPS projections
for Photocure ASA?

How accurate were the past EPS estimates
for Photocure ASA?

What are the EBIT projections
for Photocure ASA?

How accurate were the past EBIT estimates
for Photocure ASA?

Compare the revenue forecasts
for Photocure ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Photocure ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Photocure ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Photocure ASA compared to its peers.

Compare the P/E ratios
of Photocure ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Photocure ASA with its peers.

Analyze the financial leverage
of Photocure ASA compared to its main competitors.

Show all profitability ratios
for Photocure ASA.

Provide ROE
for Photocure ASA.

Provide ROA
for Photocure ASA.

Provide ROIC
for Photocure ASA.

Provide ROCE
for Photocure ASA.

Provide Gross Margin
for Photocure ASA.

Provide Operating Margin
for Photocure ASA.

Provide Net Margin
for Photocure ASA.

Provide FCF Margin
for Photocure ASA.

Show all solvency ratios
for Photocure ASA.

Provide D/E Ratio
for Photocure ASA.

Provide D/A Ratio
for Photocure ASA.

Provide Interest Coverage Ratio
for Photocure ASA.

Provide Altman Z-Score Ratio
for Photocure ASA.

Provide Quick Ratio
for Photocure ASA.

Provide Current Ratio
for Photocure ASA.

Provide Cash Ratio
for Photocure ASA.

What is the historical Revenue growth
over the last 5 years for Photocure ASA?

What is the historical Net Income growth
over the last 5 years for Photocure ASA?

What is the current Free Cash Flow
of Photocure ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Photocure ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Photocure ASA

Current Assets 387.6m
Cash & Short-Term Investments 267m
Receivables 85.9m
Other Current Assets 34.7m
Non-Current Assets 325.9m
PP&E 35.9m
Intangibles 248.2m
Other Non-Current Assets 41.8m
Current Liabilities 66.7m
Accounts Payable 16.2m
Other Current Liabilities 50.4m
Non-Current Liabilities 147.3m
Other Non-Current Liabilities 147.3m
Efficiency

Earnings Waterfall
Photocure ASA

Revenue
513.6m NOK
Cost of Revenue
-28.1m NOK
Gross Profit
485.4m NOK
Operating Expenses
-445.4m NOK
Operating Income
40m NOK
Other Expenses
-27.2m NOK
Net Income
12.8m NOK

Free Cash Flow Analysis
Photocure ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PHO Profitability Score
Profitability Due Diligence

Photocure ASA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
40/100
Profitability
Score

Photocure ASA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

PHO Solvency Score
Solvency Due Diligence

Photocure ASA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
79/100
Solvency
Score

Photocure ASA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHO Price Targets Summary
Photocure ASA

Wall Street analysts forecast PHO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHO is 99.28 NOK with a low forecast of 85.85 NOK and a high forecast of 126 NOK.

Lowest
Price Target
85.85 NOK
63% Upside
Average
Price Target
99.28 NOK
88% Upside
Highest
Price Target
126 NOK
139% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PHO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PHO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Photocure ASA Logo
Photocure ASA

Country

Norway

Industry

Pharmaceuticals

Market Cap

1.4B NOK

Dividend Yield

0%

Description

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

Contact

OSLO
Oslo
Hoffsveien 4
+4722062210.0
www.photocure.com

IPO

2000-05-29

Employees

89

Officers

President & CEO
Mr. Daniel Schneider
Chief Financial Officer
Mr. Erik Dahl
Head of Investor Relations
Mr. David Moskowitz
Head of Global Human Resources
Anja Gossens-von der Heidt
Chief Medical Officer of Global Medical Affairs, Clinical Development and R&D
Dr. Anders Neijber M.D.
Group Controller
Mr. Tolv Hillestad

See Also

Discover More
What is the Intrinsic Value of one PHO stock?

The intrinsic value of one PHO stock under the Base Case scenario is 69.19 NOK.

Is PHO stock undervalued or overvalued?

Compared to the current market price of 52.8 NOK, Photocure ASA is Undervalued by 24%.

Back to Top